Перфторуглероды в акушерстве. Реальность и перспективы

В. Е. Радзинский, А. А. Оразмурадов, Галина Татьяна Вадимировна et al. · Вестник Российского университета дружбы народов. Серия: Медицина · 2002

We inspected 66 women with heavy gestosis at gestational age 26-38 weeks. Patients were divided into 2 groups depending on Perftoran infusion use in intensive therapy only osmoon-cotherapy and receiving in quantity 3-4 ml per kg of weight once per 2 days, amount of application 3-4 times. Purpose of research: determine the possibility of Perftoran infusion in obstetric practice, in particular its application in complex treatment of placental insufficiency at heavy gestosis. Methods of research: clinical, laboratory, ultrasonic, dopplerometric. Results of research: the addition of Perftoran in complex therapy resulted to much fast stabilization of haemodinamicy, metabolism, opportunity to prolonge pregnancy till 37-38 weeks. The inclusion Perftoran in complex therapy of heavy gestosis is pathogeneticaly proved, allows to not admit gestosis aggravation and development of sevier placental insufficiency.

Cited by 0 works.

Authors